How has CorMedix's proceeds from sale of short term investments changed year-over-year?

CorMedix's proceeds from sale of short term investments decreased by 62.3% year-over-year, from $9.8M to $3.69M.

What is the long-term trend for CorMedix's proceeds from sale of short term investments?

Over 4 years (2021 to 2025), CorMedix's proceeds from sale of short term investments has grown at a 64.3% compound annual growth rate (CAGR), from $7.58M to $55.29M.

CorMedix CRMD Proceeds From Sale Of Short Term Investments

Proceeds From Sale Of Short Term Investments at other companies

Monolithic Power SystemsMPWR

$14.44M-89.8%

CSXCSX

$5M-92.5%

Southern CopperSCCO

$423.58M+75.4%

FedExFDX

$27.5M+189%

Advanced Micro DevicesAMD

$126M+282%

Electronic ArtsEA

$42M-87.2%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfShortTermInvestments.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's proceeds from sale of short term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's proceeds from sale of short term investments?: CorMedix (CRMD) reported proceeds from sale of short term investments of $3.69M in Q1 2026.
How has CorMedix's proceeds from sale of short term investments changed year-over-year?: CorMedix's proceeds from sale of short term investments decreased by 62.3% year-over-year, from $9.8M to $3.69M.
What is the long-term trend for CorMedix's proceeds from sale of short term investments?: Over 4 years (2021 to 2025), CorMedix's proceeds from sale of short term investments has grown at a 64.3% compound annual growth rate (CAGR), from $7.58M to $55.29M.